Fragment Based Lead Discovery

Date: Tuesday, 13 March 2012 - Wednesday, 14 March 2012
Location: Munich, Germany

Keynote Speakers

,	Vicki Nienaber CSO, Zenobia Therapeutics, Inc.

Overview

Welcome to the Fragment Binding Lead Discovery track of the Discovery Chemistry Congress and exhibition. This year's event will be held in Munich, Germany.

Other conference tracks at this event include Structural & Computational Chemistry, Formulation & Solubility and Chemistry Outsourcing. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.

Agenda Topics

Computational Aspects
Fragment Screening
Implementation and Applications in Drug Discovery
NMR Based Fragment Screening Technologies
The Suitability of SPR Based Fragment Screening

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

, ,
, ,
John Christopher, Associate Director, Heptares Therapeutics Limited
Chun-Wa Chung, Research Manager, GlaxoSmithKline
Helena Danielson, Professor, Uppsala University
Iwan De Esch, Associate Professor, VU University Amsterdam
Stefan Geschwindner, Principal Scientist, AstraZeneca R&D Molndal
Doris Hafenbradl, Senior Director, Biofocus
Andreas Heine, Head of X-ray Crystallography, Philipps Universitat Marburg
Andrew Hopkins, Professor, University of Dundee
Peter Johnson, Research Professor, University of Leeds
Rob Montfort, Leader, The Institute of Cancer Research
Simon Pettit, Group Leader, Selcia Ltd
Jean-Louis Reymond, Professor, The University of Bern
Gordon Saxty, Associate Director/Chair, Astex Therapeutics
Gregg Siegal, Professor, Leiden University